Our mission is to streamline clinical research to bring new medications to market faster. We are creating a holistic paperless platform for conducting clinical trials that will reduce data errors, streamline regulatory workflows and accelerate timelines.
Raymond Nomizu, JD (far right) has had first-hand experience in the shortcomings of paper-source charts. Several years ago, Raymond owned a research site in Boston and navigated the challenges of managing the ever-increasing complexity of research protocols. But he had a solution. Raymond shared his vision with Phuc Truong (far left), a technologist and serial entrepreneur, and together they launched Clinical Research IO (CRIO).
The experts at CRIO are “solutionists.” After pioneering the commercialization of eSource and delivering the industry’s first-ever Electronic Delegation Log, the first is still the best. CRIO has partnered with over 600 sites globally, and growing, all aligned with our vision of moving research forward. Today, we’re considered among the most innovative tech companies in the clinical trials industry. Our software delivery pipeline is always open, fueled by a limitless flow of creativity and innovation.
CRIO actively recruits from some of the most elite institutions across the United States. Our corporate culture supports an empowered, diverse and inventive team of industry professionals who take a novel approach to problem-solving. Life at CRIO is more than just a job. It’s a calling.
In 2020, CRIO more than doubled in revenue and tripled in employees. Periods of rapid growth are high risk and…Industry
Should we be learning how to cope with the complexity of remote/virtual monitoring, or is it more important that we…Industry
Remote consent is one of the main technological and operational advantages that supports direct-to-patient recruitment. In Part 3 of our…